Pentagastrin-induced gastric acid secretion in the diabetic rats: Role of insulin

Chinese Journal of Physiology

Volumn 47, Issue 4, 2004, Pages 175-181

  Chang, Full Young ^a   Chen, Tseng Shing ^a   Lee, Shou Dong ^a   Doong, Ming Luen ^b   Yeh, Guey Hwa ^b   Wang, Paulus S ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Diabetes; Gastric acid; Gastric inhibitory polypeptide; Insulin; Pentagastrin

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; INSULIN; PENTAGASTRIN;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; HYPERGLYCEMIA; INSULIN INFUSION; INSULIN TREATMENT; MALE; NONHUMAN; RAT; STATISTICAL ANALYSIS; STOMACH ACID SECRETION; STREPTOZOCIN DIABETES; TIME; TITRIMETRY;

EID: 11344269791     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Alam, M.J. and Buchanan, K.D. Conflicting gastric inhibitory polypeptide data: possible causes. Diabetes Res. Clin. Pract. 19: 93-100, 1993.
2. Barnett, J.L. and Owyang, C. Serum glucose concentration as a modulator of interdigestive gastric motility. Gastroenterology 94: 739-744, 1988.
3. Burghen, G.A., Murrell, L.R., Whitington, C.L., Klyce, M.K. and Burstein, S. Acid peptic disease in children with type 1 diabetes mellitus. Am. J. Dis. Child. 146: 718-722, 1992.
4. Buysschaert, M., Donckier, J., Dive, A., Ketelslegers, J.M. and Lambert, A.E. Gastric acid and pancreatic polypeptide responses to sham feeding are impaired in diabetic subjects with autonomic neuropathy. Diabetes 34:1181-1185, 1985.
5. Chang, F.Y., Lee, S.D., Yeh, G.H. and Wang, P.S. Influence of blood glucose levels on rat liquid gastric emptying. Dig. Dis. Sci. 41: 528-532, 1996.
6. Chang, F.Y., Chen, T.S., Lee, S.D., Doong, M.L. and Wang, P.S. Misoprostol inhibited rat gastric emptying is independent on gastric inhibitory polypeptide release. Pharmacology 58: 265-269, 1999.
7. Chang, F.Y., Chen, T.S., Yeh, G.H., Doong, M.L. and Wang, P.S. The acid inhibitory potency of ranitidine on the diabetic rats. Pharmacology 66: 5-10, 2002.
8. Chen, T.S., Yeh, G.H., Pu, H.F., Doong, M.L., Lu, C.C., Liu, S.R., Young, T.K., Ho, L.T., Chang, F.Y. and Wang, P.S. Gastric inhibitory polypeptide and gastric acid secretion in pregnant rats. Placenta 16: 85-92, 1995.
9. Ekelund, M., Hakanson, R., Hedenbro, J., Liedberg, G., Lundquist, I., Rehfeld, J.F. and Sundler, F. Effects of insulin on serum gastrin concentrations, gastric acid secretion and histamine mobilization in the rat. Acta Physiol. Scand. 114: 17-29, 1982.
10. Elahi, D., McAloon-Dyke, M., Fukagawa, N.K., Meneilly, G.S., Sclater, A.L., Minaker, K.L., Habener, J.F. and Andersen D.A. The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects. Regul. Pept. 39: 63-74, 1994.
11. Ensinck, JW. and D'Alessio, D.A. The enteroinsular axis revisited, a novel role for an incretin. N. Engl. J. Med. 326: 1352-1353, 1992.
12. Feldman, M., Corbett, D.B., Ramsey, E.J., Walsh, J.H. and Richardson, C.T. Abnormal gastric function in longstanding, insulin-dependent diabetic patients. Gastroenterology 77: 12-17, 1979.
13. Gillespie, G., Gillespie, I.E. and Kay, A.W. An analysis of the insulin test after vagotomy using single and multiple criteria. Gut 9: 470-474, 1968.
14. Habener, J.F. The incretin notion and its relevance to diabetes. Endocrinol. Metab. Clin. North. Am. 22, 775-794, 1993.
15. Hirano, T. and Niijima, A. Effects of 2-deoxy-D-glucose and insulin on efferent activity in gastric nerve. Experientia 36: 1197-1198, 1980.
16. Holst, J.J. and Christiansen, K. The effect of intravenous glucose on pentagastrin-induced gastric acid secretion in man. Acta Chir. Scand. 141: 289-291, 1975.
17. Jakobsen, J. Axonal dwindling in early experimental diabetes, a study of cross sectioned nerves. Diabetologia 12: 539-546, 1976.
18. Kranip, T., Madsbad, S. and Moody, A.J. Gastric inhibitory polypeptide in newly diagnosed ketotic type 1 (insulin-dependent) diabetics. Acta Med. Scand. 223: 437-441, 1988.
19. Krarup, T. and Groop, P.H. Physiology and pathophysiology of GEP: a review. Scand. J. Clin. Lab. Invest. 51: 571-579, 1991.
20. Lam, W.F., Masclee, A.A.M., de Boer, S.Y. and Lamers, C.B.H.W. Hyperglycemia reduces gastric secretory and plasma pancreatic polypeptide responses to modified sham feeding in humans. Digestion 54: 48-53, 1993.
21. Lin, C.Y., Yeh, G.H., Hsu, F.C., Tsai, S.C., Lau, C.P., Pu, H.F., Yu, H.L., Tung, Y.F. and Wang, P.S. Gastric acid secretion in streptozotocin-diabetic female rats. Chinese J. Physiol. 34: 179-186, 1991.
22. Loud, F.B., Holst, J.J., Rehfeld, J.F. and Christiansen, J. Inhibition of gastric acid secretion in humans by glucagon during euglycemia, hyperglycemia and hypoglycemia. Dig. Dis. Sci. 33: 530-534, 1988.
23. Marks, V., Morgan, L., Oben, J. and Elliott, R. Gut hormones in glucose homeostasis. Proc. Nutr. Soc. 50: 545-552, 1991.
24. Maxwell, V., Shulkes, W., Brown, J.C., Solomon, T.E., Walsh, J.H. and Grossman, M.I. Effect of gastric inhibitory polypeptide on pentagastrin-stimulated acid secretion in man. Dig. Dis. Sci. 25: 113-1136, 1980.
25. Nauck, M.A., Bartels, E., Orskov, C., Ebert, R. and Creutafeldt, W. Lack of effect of synthetic human gastric inhibitory polypeptide and glucagon-like peptide 1 [7-36 amide] infused at near-physiological concentrations on pentagastrin-stimulated gastric acid secretion in normal human subjects. Digestion 52: 214-221, 1992.
26. Ozcelikay, A.T., Altan, M., Yildizoglu-Ari, N., Altinkurt, O., Onur, F. and Ozturk, Y. Basal and histamine-induced gastric acid secretion in alloxan diabetic rats. Gen. Pharmac-ol. 24: 121-126, 1993.
27. Qvigstad, G., BjÖrgaas, M., Eide, I., Sandvik, A.K. and Waldum, H.L. Vagal stimulation augments maximal (pental) gastrin-stimulated acid secretion in humans. Acta Physiol. Scand. 165: 277-281, 1999.
28. 2 fragment with potent pancreatic amylase inhibitor activity. Regul. Pept. 39: 9-17, 1992.
29. Soll, A.H. The actions of secretagogues on oxygen uptake by isolated mammalian parietal cells. J. Clin. Invest. 61: 370-380, 1978.
30. Takeuchi, K., Ueshima, K., Ohuchi, T. and Okabe, S. Induction of gastric lesions and hypoglycemic response by food deprivation in streptozotocin-diabetic rats. Dig. Dis. Sci. 39: 626-634, 1994.
31. Tashima, K., Nishijima, M., Fujita, A., Kubomi, M. and Takeuchi K. Acid secretory changes in streptozotocin-diabetic rats, different responses to various secretagogues. Dig. Dis. Sci. 45: 1352-1358, 2000.
32. Tashima, K., Nishijima, M., Fujita, A., Kawauchi, S. and Takeuchi, K. Gastric acid secretion in streptozotocin-diabetic rats-Different responses to various secretagogues. J. Physiol. (Paris 94: 11-17, 2000.